Without an extension of premium tax credits, millions may lose their health insurance. This analysis highlights the potential healthcare crisis ahead.

This article explores how Trump’s second term might affect life insurance and annuity industries, focusing on regulatory changes and fiduciary responsibilities.

CVS confronts significant financial hurdles in 2024, primarily due to rising medical costs impacting Aetna's performance and leadership changes. Read about their strategies for recovery.

The OIG warns of inaccuracies in Medicare Advantage risk payments linked to health assessments, proposing CMS audits and stricter regulations.

Humana Inc. files lawsuit against HHS over Medicare Advantage star ratings drop, affecting revenue and quality assessment, amid expansion of health services.

Humana's CEO announces plans to improve Medicare Advantage star ratings through increased investment, aiming to enhance performance for members and investors.

Ceci Connolly discusses key aspects of the 2024 election's implications for the healthcare industry, focusing on drug pricing, telehealth, and the dynamics between major candidates.

Explore how a simple reform to Medicare's prescription drug program could save billions for seniors, improve chronic illness management, and lower health costs. Learn about the stalled Share the Savings with Seniors Act and its potential impact on healthcare affordability.

Delaware's Medicare Assistance Bureau is urging residents to prepare for the upcoming Open Enrollment period with free counseling and important updates on Medicare coverage options and changes for 2025.

The CBO's analysis indicates that the Biden-Harris Medicare Part D Premium Stabilization Program may cost taxpayers over $21 billion over three years, raising concerns about escalating healthcare costs for seniors.